On Thursday, Cardinal Health Inc (NYSE:CAH)’s shares declined -2.94% to $84.27.
Cardinal Health Inc (CAH) declared the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners. The $1.115 billion acquisition was an all-cash transaction using existing cash and new debt.
Headquartered in Livonia, Mich., The Harvard Drug Group had revenues of about $450 million in 2014. There are 450 employees and two distribution facilities comprised of in the transaction.
In addition to enhancing the company’s generic pharmaceutical distribution business, the acquisition expands Cardinal Health’s existing telesales programs and capabilities; broadens the company’s portfolio of over-the counter pharmaceutical products; and brings specialized packaging offerings to meet the needs of hospital systems and other institutions.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
Biogen Inc (NASDAQ:BIIB)’s shares dropped -1.71% to $385.05.
A chronic disease like relapsing MS (RMS) can complicate common aspects of everyday life, and a new program from Biogen (BIIB) and SELF is helping women navigate these familiar issues. Reimagine MySelf, which is now available on SELF.com, provides women access to editorial content and an exclusive blog series where writers from the SELF Made Blogger Collective and experts offer their best practical advice on style, entertaining, travel, healthy eating and more. Personal tips for women living with RMS are incorporated into all of the blogs to ensure their relevance and meaning for those facing an RMS diagnosis.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohn’s disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), in addition to two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with formerly untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients.
At the end of Thursday’s trade, Talen Energy Corp (NYSE:TLN)‘s shares dipped -4.93% to $15.99.
Talen Energy Corporation (TLN) plans to declare second quarter 2015 financial results before the stock market opens on Tuesday, Aug. 11.
President and Chief Executive Officer Paul Farr and other members of the executive team will talk about quarterly results and the company’s general business outlook during a conference call and webcast that will start at 8:30 a.m. Eastern time.
Talen Energy Corporation operates as an independent power producer in the United States. It has a portfolio of carbon-free nuclear power, natural gas generation, and coal-fired generation assets. The company owns about 15,000 megawatts of generating capacity, primarily located in the Mid-Atlantic and Texas regions.
PepsiCo, Inc. (NYSE:PEP), ended its Thursday’s trading session with -0.31% loss, and closed at $96.87.
The Board of Directors of PepsiCo, Inc. (PEP) declared a quarterly dividend of $0.7025 per share of PepsiCo common stock, a 7.3 percent enhance as compared to the comparable year-earlier period. The dividend is payable on September 30, 2015 to shareholders of record as of September 4, 2015. PepsiCo has paid successive quarterly cash dividends since 1965, and 2015 marks the company’s 43rd successive annual dividend enhance.
PepsiCo, Inc. operates as a food and beverage company worldwide. Its Frito-Lay North America segment offers Lay’s potato chips, Doritos tortilla chips, Cheetos cheese-flavored snacks, Tostitos tortilla chips, branded dips, Ruffles potato chips, Fritos corn chips, and Santitas tortilla chips.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.